{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:51:22Z","timestamp":1793047882047,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1186\/1471-2407-10-666","type":"journal-article","created":{"date-parts":[[2010,12,3]],"date-time":"2010-12-03T14:14:05Z","timestamp":1291385645000},"source":"Crossref","is-referenced-by-count":100,"title":["Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients"],"prefix":"10.1186","volume":"10","author":[{"given":"Eva","family":"Obermayr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Sanchez-Cabo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muy-Kheng M","family":"Tea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian F","family":"Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Krainer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jalid","family":"Sehouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Reinthaller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard","family":"Horvat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Heinze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Zeillinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,12,3]]},"reference":[{"key":"2465_CR1","unstructured":"GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide. [ http:\/\/www-dep.iarc.fr ]"},{"key":"2465_CR2","first-page":"146","volume":"14","author":"T Ashworth","year":"1869","unstructured":"Ashworth T: A case of cancer in which cells similar to those in the tumours were seen in the blood after death. Aus Med J. 1869, 14: 146-149.","journal-title":"Aus Med J"},{"issue":"2","key":"2465_CR3","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.canlet.2006.12.014","volume":"253","author":"P Paterlini-Brechot","year":"2007","unstructured":"Paterlini-Brechot P, Benali NL: Circulating tumor cells (CTC) detection: clinical impact and future directions. Cancer Lett. 2007, 253 (2): 180-204. 10.1016\/j.canlet.2006.12.014.","journal-title":"Cancer Lett"},{"issue":"1","key":"2465_CR4","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/sj.bjc.6602871","volume":"94","author":"JB Smerage","year":"2006","unstructured":"Smerage JB, Hayes DF: The measurement and therapeutic implications of circulating tumour cells in breast cancer. Br J Cancer. 2006, 94 (1): 8-12. 10.1038\/sj.bjc.6602871.","journal-title":"Br J Cancer"},{"issue":"4","key":"2465_CR5","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1677\/ERC-06-0001","volume":"13","author":"M Lacroix","year":"2006","unstructured":"Lacroix M: Significance, detection and markers of disseminated breast cancer cells. Endocr Relat Cancer. 2006, 13 (4): 1033-1067. 10.1677\/ERC-06-0001.","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"2465_CR6","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1080\/10408360590913696","volume":"42","author":"V Zieglschmid","year":"2005","unstructured":"Zieglschmid V, Hollmann C, Bocher O: Detection of disseminated tumor cells in peripheral blood. Crit Rev Clin Lab Sci. 2005, 42 (2): 155-196. 10.1080\/10408360590913696.","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"3","key":"2465_CR7","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1002\/cncr.10250","volume":"94","author":"C Marth","year":"2002","unstructured":"Marth C, Kisic J, Kaern J, Trope C, Fodstad O: Circulating tumor cells in the peripheral blood and bone marrow of patients with ovarian carcinoma do not predict prognosis. Cancer. 2002, 94 (3): 707-712. 10.1002\/cncr.10250.","journal-title":"Cancer"},{"issue":"2","key":"2465_CR8","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.ygyno.2007.07.073","volume":"107","author":"P Wimberger","year":"2007","unstructured":"Wimberger P, Heubner M, Otterbach F, Fehm T, Kimmig R, Kasimir-Bauer S: Influence of platinum-based chemotherapy on disseminated tumor cells in blood and bone marrow of patients with ovarian cancer. Gynecol Oncol. 2007, 107 (2): 331-338. 10.1016\/j.ygyno.2007.07.073.","journal-title":"Gynecol Oncol"},{"key":"2465_CR9","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/0002-9378(59)90530-7","volume":"78","author":"AW Diddle","year":"1959","unstructured":"Diddle AW, Sholes DM, Hollingsworth J, Kinlaw S: Cervical carcinoma; cancer cells in the circulating blood. Am J Obstet Gynecol. 1959, 78: 582-585.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"2465_CR10","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1006\/gyno.2000.6067","volume":"80","author":"H Yabushita","year":"2001","unstructured":"Yabushita H, Shimazu M, Yamada H, Sawaguchi K, Noguchi M, Nakanishi M, Kawai M: Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in node-negative endometrial cancer. Gynecol Oncol. 2001, 80 (2): 139-144. 10.1006\/gyno.2000.6067.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"2465_CR11","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.ygyno.2005.08.041","volume":"100","author":"XQ Ji","year":"2006","unstructured":"Ji XQ, Sato H, Tanaka H, Konishi Y, Fujimoto T, Takahashi O, Tanaka T: Real-time quantitative RT-PCR detection of disseminated endometrial tumor cells in peripheral blood and lymph nodes using the LightCycler System. Gynecol Oncol. 2006, 100 (2): 355-360. 10.1016\/j.ygyno.2005.08.041.","journal-title":"Gynecol Oncol"},{"issue":"8","key":"2465_CR12","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1056\/NEJMoa040766","volume":"351","author":"M Cristofanilli","year":"2004","unstructured":"Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ, Terstappen LW, et al: Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med. 2004, 351 (8): 781-791. 10.1056\/NEJMoa040766.","journal-title":"N Engl J Med"},{"issue":"7","key":"2465_CR13","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1200\/JCO.2005.08.140","volume":"23","author":"M Cristofanilli","year":"2005","unstructured":"Cristofanilli M, Hayes DF, Budd GT, Ellis MJ, Stopeck A, Reuben JM, Doyle GV, Matera J, Allard WJ, Miller MC, et al: Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. J Clin Oncol. 2005, 23 (7): 1420-1430. 10.1200\/JCO.2005.08.140.","journal-title":"J Clin Oncol"},{"issue":"6","key":"2465_CR14","doi-asserted-by":"publisher","first-page":"R975","DOI":"10.1186\/bcr1328","volume":"7","author":"K Pachmann","year":"2005","unstructured":"Pachmann K, Camara O, Kavallaris A, Schneider U, Schunemann S, Hoffken K: Quantification of the response of circulating epithelial cells to neodadjuvant treatment for breast cancer: a new tool for therapy monitoring. Breast Cancer Res. 2005, 7 (6): R975-979. 10.1186\/bcr1328.","journal-title":"Breast Cancer Res"},{"issue":"6","key":"2465_CR15","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3816\/CBC.2007.n.004","volume":"7","author":"M Cristofanilli","year":"2007","unstructured":"Cristofanilli M, Broglio KR, Guarneri V, Jackson S, Fritsche HA, Islam R, Dawood S, Reuben JM, Kau SW, Lara JM, et al: Circulating tumor cells in metastatic breast cancer: biologic staging beyond tumor burden. Clin Breast Cancer. 2007, 7 (6): 471-479. 10.3816\/CBC.2007.n.004.","journal-title":"Clin Breast Cancer"},{"issue":"1","key":"2465_CR16","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/jnci\/djn419","volume":"101","author":"AM Sieuwerts","year":"2009","unstructured":"Sieuwerts AM, Kraan J, Bolt J, van der Spoel P, Elstrodt F, Schutte M, Martens JW, Gratama JW, Sleijfer S, Foekens JA: Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells. J Natl Cancer Inst. 2009, 101 (1): 61-66.","journal-title":"J Natl Cancer Inst"},{"key":"2465_CR17","unstructured":"Medical devices; immunology and microbiology devices; classification of the immunomagnetic circulating cancer cell selection and enumeration system. Final rule. Fed Regist. 2004, 69 (91): 26036-26038."},{"issue":"1-2","key":"2465_CR18","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s004040050251","volume":"263","author":"XY Zhong","year":"1999","unstructured":"Zhong XY, Kaul S, Eichler A, Bastert G: Evaluating GA733-2 mRNA as a marker for the detection of micrometastatic breast cancer in peripheral blood and bone marrow. Arch Gynecol Obstet. 1999, 263 (1-2): 2-6. 10.1007\/s004040050251.","journal-title":"Arch Gynecol Obstet"},{"issue":"2C","key":"2465_CR19","first-page":"1883","volume":"23","author":"A Stathopoulou","year":"2003","unstructured":"Stathopoulou A, Mavroudis D, Perraki M, Apostolaki S, Vlachonikolis I, Lianidou E, Georgoulias V: Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers. Anticancer Res. 2003, 23 (2C): 1883-1890.","journal-title":"Anticancer Res"},{"issue":"8","key":"2465_CR20","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/S0009-9120(01)00276-4","volume":"34","author":"A Stathopoulou","year":"2001","unstructured":"Stathopoulou A, Angelopoulou K, Perraki M, Georgoulias V, Malamos N, Lianidou E: Quantitative RT-PCR luminometric hybridization assay with an RNA internal standard for cytokeratin-19 mRNA in peripheral blood of patients with breast cancer. Clin Biochem. 2001, 34 (8): 651-659. 10.1016\/S0009-9120(01)00276-4.","journal-title":"Clin Biochem"},{"issue":"2","key":"2465_CR21","first-page":"265","volume":"24","author":"S Roncella","year":"2005","unstructured":"Roncella S, Ferro P, Bacigalupo B, Pronzato P, Tognoni A, Falco E, Gianquinto D, Ansaldo V, Dessanti P, Fais F, et al: Human mammaglobin mRNA is a reliable molecular marker for detecting occult breast cancer cells in peripheral blood. J Exp Clin Cancer Res. 2005, 24 (2): 265-271.","journal-title":"J Exp Clin Cancer Res"},{"issue":"10","key":"2465_CR22","doi-asserted-by":"publisher","first-page":"R80","DOI":"10.1186\/gb-2004-5-10-r80","volume":"5","author":"RC Gentleman","year":"2004","unstructured":"Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, et al: Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004, 5 (10): R80-10.1186\/gb-2004-5-10-r80.","journal-title":"Genome Biol"},{"key":"2465_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF02595811","volume":"12","author":"YDS Ge","year":"2003","unstructured":"Ge YDS, Speed TP: Resampling-based multiple testing for microarray data analysis. Test. 2003, 12: 1-44. 10.1007\/BF02595811.","journal-title":"Test"},{"key":"2465_CR24","unstructured":"Gleiss A, Sanchez-Cabo F, Perco P, Tong D, Heinze G: Adaptive trimmed t-statistics for identifying predominantly high expression in a microarray experiment. Stat Med."},{"issue":"4","key":"2465_CR25","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/nbt0402-387","volume":"20","author":"CA Klein","year":"2002","unstructured":"Klein CA, Seidl S, Petat-Dutter K, Offner S, Geigl JB, Schmidt-Kittler O, Wendler N, Passlick B, Huber RM, Schlimok G, et al: Combined transcriptome and genome analysis of single micrometastatic cells. Nat Biotechnol. 2002, 20 (4): 387-392. 10.1038\/nbt0402-387.","journal-title":"Nat Biotechnol"},{"key":"2465_CR26","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1471-2407-8-55","volume":"8","author":"K Mikhitarian","year":"2008","unstructured":"Mikhitarian K, Martin RH, Ruppel MB, Gillanders WE, Hoda R, Schutte del H, Callahan K, Mitas M, Cole DJ: Detection of mammaglobin mRNA in peripheral blood is associated with high grade breast cancer: interim results of a prospective cohort study. BMC Cancer. 2008, 8: 55-10.1186\/1471-2407-8-55.","journal-title":"BMC Cancer"},{"key":"2465_CR27","volume-title":"European Patent No. 1786929","author":"R Zeillinger","year":"2006","unstructured":"Zeillinger R, Fabjani G: Method and kit for diagnosis of a cancerous disease, method for determining the reaction of a patient to the treatment for a cancerous disease, medicament for the prophylaxis or treatment of a cancerous disease. European Patent No. 1786929. 2006"},{"issue":"2","key":"2465_CR28","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.canlet.2008.01.003","volume":"263","author":"A Gervasoni","year":"2008","unstructured":"Gervasoni A, Monasterio Munoz RM, Wengler GS, Rizzi A, Zaniboni A, Parolini O: Molecular signature detection of circulating tumor cells using a panel of selected genes. Cancer Lett. 2008, 263 (2): 267-279. 10.1016\/j.canlet.2008.01.003.","journal-title":"Cancer Lett"},{"key":"2465_CR29","doi-asserted-by":"crossref","unstructured":"Konigsberg R, Gneist M, Jahn-Kuch D, Pfeiler G, Hager G, Hudec M, Dittrich C, Zeillinger R: Circulating tumor cells in metastatic colorectal cancer: efficacy and feasibility of different enrichment methods. Cancer Lett. 293 (1): 117-123. 10.1016\/j.canlet.2010.01.003.","DOI":"10.1016\/j.canlet.2010.01.003"},{"issue":"20","key":"2465_CR30","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.1038\/sj.onc.1202477","volume":"17","author":"N Lauper","year":"1998","unstructured":"Lauper N, Beck AR, Cariou S, Richman L, Hofmann K, Reith W, Slingerland JM, Amati B: Cyclin E2: a novel CDK2 partner in the late G1 and S phases of the mammalian cell cycle. Oncogene. 1998, 17 (20): 2637-2643. 10.1038\/sj.onc.1202477.","journal-title":"Oncogene"},{"issue":"10","key":"2465_CR31","doi-asserted-by":"publisher","first-page":"3678","DOI":"10.1158\/1078-0432.CCR-04-2469","volume":"11","author":"V Muller","year":"2005","unstructured":"Muller V, Stahmann N, Riethdorf S, Rau T, Zabel T, Goetz A, Janicke F, Pantel K: Circulating tumor cells in breast cancer: correlation to bone marrow micrometastases, heterogeneous response to systemic therapy and low proliferative activity. Clin Cancer Res. 2005, 11 (10): 3678-3685. 10.1158\/1078-0432.CCR-04-2469.","journal-title":"Clin Cancer Res"},{"issue":"10","key":"2465_CR32","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/S0168-9525(97)01244-4","volume":"13","author":"F Forozan","year":"1997","unstructured":"Forozan F, Karhu R, Kononen J, Kallioniemi A, Kallioniemi OP: Genome screening by comparative genomic hybridization. Trends Genet. 1997, 13 (10): 405-409. 10.1016\/S0168-9525(97)01244-4.","journal-title":"Trends Genet"},{"issue":"5","key":"2465_CR33","first-page":"1107","volume":"152","author":"S Knuutila","year":"1998","unstructured":"Knuutila S, Bjorkqvist AM, Autio K, Tarkkanen M, Wolf M, Monni O, Szymanska J, Larramendy ML, Tapper J, Pere H, et al: DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies. Am J Pathol. 1998, 152 (5): 1107-1123.","journal-title":"Am J Pathol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-10-666.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-10-666\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-10-666","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T15:48:28Z","timestamp":1559836108000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-10-666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["2465"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-10-666","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12]]},"article-number":"666"}}